USPTO serial 79438399
NEUROPRENE
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- TMO LAW OFFICE 111
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEUROPRENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandy Lipkin
Sandy Lipkin Patent Hatchery LLC7 Clifton CourtPikesville, MD 21208United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Germicides; balms for medical purposes; dietetic foods adapted for medical use; guaiacol for pharmaceutical purposes; dietary supplements for human beings; mineral dietary supplements; nutritional supplements; albumin dietary supplements; dietary supplements for animals; yeast dietary supplements; alginate dietary supplements; glucose dietary supplements; casein dietary supplements; lecithin dietary supplements; linseed oil dietary supplements; brewer's yeast dietary supplements; propolis dietary supplements; protein dietary supplements; royal jelly dietary supplements; pollen dietary supplements; wheat germ dietary supplements; linseed dietary supplements; whey protein dietary supplements; dietary supplements with a cosmetic effect; enzyme dietary supplements; haemostatic pencils; medicinal roots; medicated hair lotions; skin lotions for pharmaceutical purposes; liniments; antibiotic ointments for pharmaceutical purposes; sunburn ointments; frostbite salve for pharmaceutical purposes; drugs for medical purposes, namely, for the treatment of neurodegenerative disease; herbal tinctures for medical purposes; mouthwashes for medical purposes; medicated toothpaste; balsamic preparations for medical purposes; vitamin preparations; diagnostic preparations for medical purposes; bath preparations for medical purposes; therapeutic preparations for the bath; pharmaceutical preparations for skin care; nutraceutical preparations for therapeutic or medical purposes for the treatment of neurodegenerative disease; aloe vera preparations for pharmaceutical purposes; pharmaceutical preparations for the treatment of neurodegenerative disease; pharmaceutical preparations for treating sunburn; enzyme preparations for medical purposes; phytotherapy preparations for medical purposes; neuroprotective pharmaceuticals; soporifics; antibacterial handwashes; adjuvants for medical purposes; astringents for medical purposes; vermifuges; disinfectants; depuratives for the body; appetite suppressants for medical purposes; medicated dentifrices; febrifuges; purgatives; remedies for foot perspiration, namely, medicated soap for foot perspiration; antiinflammatories; antiparasitic preparations; sedatives; laxatives;; medicated toiletry preparations; skin hydrators being injectable dermal fillers; digestives for pharmaceutical purposes; headache relief sticks; appetite suppressant pills; slimming pills; antioxidant pills being food supplements; medicinal herbs; tranquillizers; enzymes for medical purposes; ferments for pharmaceutical purposes; medicinal tea; herbal teas for medicinal purposes; bath tea for therapeutic purposes; medicated shampoos; medicated dry shampoos; herbal extracts, other than essential oils, for medical purposes; plant extracts, other than essential oils, for pharmaceutical purposes; ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes | ACTIVE | — |
| 035 | Demonstration of goods; providing business information via a website; providing commercial information and advice for consumers in the choice of products and services; provision of an online marketplace for buyers and sellers of goods and services; sales promotion for others; distribution of samples; dissemination of advertising matter; administrative processing of purchase orders; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; procurement services for others, namely, purchasing goods and services featuring pharmaceutical and medical supplies for other businesses; outsourcing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 25, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 14, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |